ILARIS (canakinumab/PF)
ANTI-INFLAMMATORY - INTERLEUKIN 1 RECEPTOR ANTAGONIST · ACUTE GOUTY ARTHRITIS ·+7
Novartis Pharmaceuticals
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
JADENU (deferasirox)
IRON CHELATING AGENTS · CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS ·+1
Novartis Pharmaceuticals
JADENU SPRINKLE (deferasirox)
IRON CHELATING AGENTS · CHRONIC IRON OVERLOAD DUE TO REPEATED BLOOD TRANSFUSIONS ·+1
Novartis Pharmaceuticals
KISQALI (ribociclib succinate)
ANTINEOPLASTIC- CYCLIN-DEPENDENT KINASE (CDK) 4/6 INHIBITORS · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE ADVANCED BREAST CANCER ·+1
Novartis Pharmaceuticals
KYMRIAH (tisagenlecleucel)
ANTINEOPLASTIC - CAR-T/TCR-T CELL IMMUNOTHERAPY · B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Novartis Pharmaceuticals
LEQVIO (inclisiran sodium)
ANTIHYPERLIPIDEMIC - PCSK9 INHIBITORS · HYPERCHOLESTEROLEMIA ·+2
Novartis Pharmaceuticals
Novartis Pharmaceuticals
MAYZENT (siponimod)
MULTIPLE SCLEROSIS AGENTS, GENERAL · RELAPSING FORM OF MULTIPLE SCLEROSIS
Novartis Pharmaceuticals
MEKINIST (trametinib dimethyl sulfoxide)
ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals
MYFORTIC (mycophenolate sodium)
IMMUNOSUPPRESSIVE INOSINE MONOPHOSPHATE DEHYDROGENASE INHIB. · PREVENTION OF KIDNEY TRANSPLANT REJECTION
Novartis Pharmaceuticals
NEORAL (cyclosporine, modified)
ANTIPSORIATICS · SEVERE RECALCITRANT PSORIASIS ·+4
Novartis Pharmaceuticals
PIQRAY (alpelisib)
ANTINEOPLASTIC - PHOSPHATIDYLINOSITOL 3-KINASE ALPHA INHIB. · HORMONE RECEPTOR (HR)-POSITIVE, HER2-NEGATIVE, PIK3CA MUTATED ADVANCED BREAST CANCER
Novartis Pharmaceuticals
PLUVICTO (lutetium Lu-177 vipivotide tetraxetan)
METASTATIC PROSTATE CARCINOMA ·+1
Novartis Pharmaceuticals
PROMACTA (eltrombopag olamine)
THROMBOPOIETIC GROWTH FACTORS · APLASTIC ANEMIA ·+2
Novartis Pharmaceuticals
RHAPSIDO (remibrutinib)
SPLEEN/BRUTON'S TYROSINE KINASE INHIBITORS · CHRONIC IDIOPATHIC URTICARIA ·+1
Novartis Pharmaceuticals
RYDAPT (midostaurin)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ACUTE MYELOID LEUKEMIA WITH FMS-LIKE TYROSINE KINASE-3 (FLT3) MUTATION ·+3
Novartis Pharmaceuticals
SANDIMMUNE (cyclosporine)
ANTIPSORIATICS · PREVENTION OF KIDNEY TRANSPLANT REJECTION ·+2
Novartis Pharmaceuticals
SANDOSTATIN (octreotide acetate)
SOMATOSTATIC AGENTS · ACROMEGALY ·+2
Novartis Pharmaceuticals
SANDOSTATIN LAR DEPOT (octreotide acetate, microspheres)
SOMATOSTATIC AGENTS · ACROMEGALY ·+2
Novartis Pharmaceuticals
SCEMBLIX (asciminib hydrochloride)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
Novartis Pharmaceuticals
SIMULECT (basiliximab)
MONOCLONAL ANTIBODY IMMUNOSUPPRESSIVES · PREVENTION OF KIDNEY TRANSPLANT REJECTION
Novartis Pharmaceuticals
TABRECTA (capmatinib hydrochloride)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · NON-SMALL CELL LUNG CANCER WITH MESENCHYMAL-EPITHELIAL TRANSITION (MET) EXON 14 SKIPPING
Novartis Pharmaceuticals
TAFINLAR (dabrafenib mesylate)
ANTINEOPLASTIC - BRAF KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals
TASIGNA (nilotinib HCl)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOCYTIC LEUKEMIA ·+1
Novartis Pharmaceuticals
TEGRETOL (carbamazepine)
ANTICONVULSANTS · TONIC-CLONIC EPILEPSY ·+4
Novartis Pharmaceuticals